A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Public ClinicalTrials.gov record NCT05100199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of OnabotulinumtoxinA X for the Treatment of Moderate to Severe Glabellar Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, dose ranging study to evaluate the safety of OnabotulinumtoxinA X and to compare the efficacy of OnabotulinumtoxinA X and placebo for the treatment of Glabellar Lines in adult participants with moderate to severe GL.
Study identification
- NCT ID
- NCT05100199
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 328 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 6, 2021 (Actual)
- Primary completion
- Dec 2, 2022 (Actual)
- Completion
- Dec 2, 2022 (Actual)
- Last update posted
- Sep 9, 2025
2021 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research Associates - Glendale /ID# 230418 | Glendale | Arizona | 85308 | — |
| Westside Aesthetics /ID# 230305 | Los Angeles | California | 90025-1708 | — |
| The Eye Research Foundation /ID# 232544 | Newport Beach | California | 92663-3637 | — |
| The Research Center at The Maas Clinic /ID# 230685 | San Francisco | California | 94115-1809 | — |
| Center for Dermatology and Dermatologic Surgery /ID# 230684 | Washington D.C. | District of Columbia | 20037-1445 | — |
| Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 232542 | Boca Raton | Florida | 33431-6465 | — |
| Baumann Cosmetic and Research Institute /ID# 232545 | Miami | Florida | 33137-3254 | — |
| Research Institute of the Southeast, LLC /ID# 230436 | West Palm Beach | Florida | 33401-2712 | — |
| Coleman Center For Cosmetic Dermatologic Surgery /ID# 230693 | Metairie | Louisiana | 70006 | — |
| Etre Cosmetic Dermatology and Laser Center /ID# 230437 | New Orleans | Louisiana | 70130-4353 | — |
| SLUCare Cosmetic Dermatology /ID# 230333 | St Louis | Missouri | 63122-3379 | — |
| Laser & Skin Surgery Center of New York /ID# 230683 | New York | New York | 10016-4974 | — |
| Skin Search of Rochester Inc. /ID# 242540 | Rochester | New York | 14623 | — |
| Aesthetic Solutions /ID# 230716 | Chapel Hill | North Carolina | 27517-9901 | — |
| Wilmington Dermatology Center /ID# 242544 | Wilmington | North Carolina | 28403 | — |
| Aventiv Research Dublin /ID# 232546 | Dublin | Ohio | 43016 | — |
| Westlake Dermatology & Cosmetic Surgery - Westlake /ID# 232543 | Austin | Texas | 78746-4720 | — |
| Premier Clinical Research /ID# 230682 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05100199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05100199 live on ClinicalTrials.gov.